Role of Transforming Growth Factor-β1 in Cardiovascular Inflammatory Changes Induced by Chronic Inhibition of Nitric Oxide Synthesis

Masamichi Koyanagi, Kensuke Egashira, Mayuko Kubo-Inoue, Makoto Usui, Shiro Kitamoto, Hideharu Tomita, Hiroaki Shimokawa, Akira Takeshita

研究成果: Article査読

59 被引用数 (Scopus)

抄録

We previously reported that chronic inhibition of nitric oxide (NO) synthesis with Nω-nitro-L-arginine methyl ester (L-NAME) induces inflammatory changes (monocyte infiltration, myofibroblast formation, and monocyte chemoattractant protein-1 [MCP-1] and transforming growth factor-β1 [TGF-β1] expression) in the rat heart and vessel. There is debate regarding whether TGF-β1 exhibits proinflammatory or anti-inflammatory activities. We used the rat model to investigate the role of TGF-β in the pathogenesis of such inflammatory changes. We show here that infiltrating monocytes and myofibroblasts in the inflammatory lesions produced TGF-β1 on the third day of L-NAME administration. Cotreatment with a monoclonal antibody against TGF-β1, but not with control IgG, prevented the L-NAME-induced cardiac inflammation. The antibody also significantly inhibited the gene expression of MCP-1, P-selectin, and intercellular adhesion molecule-1. In summary, the antibody against TGF-β1 prevented inflammatory changes in rat heart and vessel induced by chronic inhibition of NO synthesis, suggesting that increased production of TGF-β1 is involved in the inflammatory changes in this model.

本文言語English
ページ(範囲)86
ページ数1
ジャーナルHypertension
35
1
DOI
出版ステータスPublished - 2000 1月

ASJC Scopus subject areas

  • 内科学

フィンガープリント

「Role of Transforming Growth Factor-β1 in Cardiovascular Inflammatory Changes Induced by Chronic Inhibition of Nitric Oxide Synthesis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル